局部麻醉用于经皮腹主动脉瘤腔内修复术与更少的肺部并发症相关
基于血管质量倡议(Vascular Quality Initiative)数据库的8141例经皮EVAR分析,比较全身麻醉(GA)与局部麻醉(LA)的围手术期结局。多变量分析显示GA与更多肺部并发症(OR 2.8,95%CI 1.49-5.43,P=.002)和更长手术时间(均值比1.11,95%CI 1.08-1.52,P<.001)独立相关,对总体并发症、心脏并发症或死亡率无独立影响。
要点
- 在8141例经皮EVAR中,仅9.3%(754例)使用局部麻醉,90.7%(7387例)使用全身麻醉。
- 多变量分析显示,与LA相比,GA与更多肺部并发症(OR 2.8,95%CI 1.49-5.43,P=.002)相关。
- GA还与更长手术时间相关(均值比1.11,95%CI 1.08-1.52,P<.001),对总体并发症、心脏并发症或死亡率无独立影响。
核心结论
- 在校正患者因素后,局部麻醉与经皮EVAR后更少的肺部并发症相关;作者建议外科医生在可行时考虑扩大局部麻醉在经皮EVAR中的应用。
研究设计与样本
- 回顾性数据库分析,查询血管质量倡议(Vascular Quality Initiative)数据库中所有完全经皮EVAR手术,共识别8141例经皮EVAR。
主要发现
- 平均年龄73岁,83%为男性;GA和LA分别用于7387例(90.7%)和754例(9.3%)。
- GA更多用于较年轻患者(72.8±8 vs 74.3±9)、白人(89% vs 84.5%)、享受Medicare(62% vs 61.5%)、体重指数较高(28.3±6 vs 27.3±7)、高血压(81.5% vs 77.8%)、糖尿病(20.5% vs 17.4%)、既往下肢旁路术(1.7% vs 0.5%)以及择期修复(86.4% vs 81.3%)的患者。
- GA与较低的术前充血性心力衰竭(11.6% vs 16.1%)、术前抗凝(11.7% vs 14.2%)和较少使用超声引导(81.5% vs 88.8%;P<.05)相关。
- 慢性阻塞性肺疾病、冠状动脉疾病、既往动脉瘤修复和同期髂动脉瘤修复的患者在麻醉类型间无差异。
- 多变量分析显示,与LA相比,GA与更多肺部并发症(OR 2.8,95%CI 1.49-5.43,P=.002)和更长手术时间(均值比1.11,95%CI 1.08-1.52,P<.001)相关;对总体并发症、心脏并发症或死亡率无独立影响。
关键数值与推荐
- GA vs LA与肺部并发症的OR 2.8(95%CI 1.49-5.43,P=.002)。
- GA vs LA与手术时间的均值比1.11(95%CI 1.08-1.52,P<.001)。
临床怎么用
- 作者建议外科医生在可行时考虑扩大局部麻醉在经皮EVAR中的应用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Percutaneous endovascular aneurysm repair (EVAR) can be performed with general anesthesia (GA) or local anesthesia (LA). Our goal was to assess perioperative outcomes comparing anesthesia type in percutaneous EVAR. METHODS: The Vascular Quality Initiative database was queried for all exclusively percutaneous EVAR procedures. Univariable analysis was used to compare which patients were offered LA. Multivariable analysis was used to determine the independent effect of anesthesia type. RESULTS: There were 8141 percutaneous EVARs identified in the Vascular Quality Initiative database. Average age was 73 years, and 83% were male. GA and LA were used in 7387 (90.7%) and 754 (9.3%) cases, respectively. GA was used more often in patients who were younger (72.8 ± 8 vs 74.3 ± 9), white (89% vs 84.5%), and on Medicare (62% vs 61.5%); in patients with higher body mass index (28.3 ± 6 vs 27.3 ± 7), hypertension (81.5% vs 77.8%), diabetes (20.5% vs 17.4%), and previous lower extremity bypass (1.7% vs 0.5%); and in patients undergoing elective repair (86.4% vs 81.3%). Use of GA was associated with lower rates of preoperative congestive heart failure (11.6% vs 16.1%), preoperative anticoagulation (11.7% vs 14.2%), and less use of ultrasound guidance (81.5% vs 88.8%; P < .05). There was no difference in patients with chronic obstructive pulmonary disease, coronary artery disease, previous aneurysm repair, and concomitant iliac aneurysm repair. Multivariable analysis showed that GA compared with LA was associated with more pulmonary complications (odds ratio, 2.8; 95% confidence interval, 1.49-5.43; P = .002) and prolonged operative time (means ratio, 1.11; 95% confidence interval, 1.08-1.52; P < .001). There was no independent effect on overall complications, cardiac complications, or mortality. CONCLUSIONS: Although it was used in only 1 in 10 cases of percutaneous EVAR, LA was associated with fewer pulmonary complications after adjustment for patient factors. Surgeons should consider expanding the use of LA for percutaneous EVAR when feasible.
引用
- Van Orden K, Farber A, Schermerhorn ML, et al. Local anesthesia for percutaneous endovascular abdominal aortic aneurysm repair is associated with fewer pulmonary complications. J Vasc Surg. 2018. PMID: 29602472. doi:10.1016/j.jvs.2017.12.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。